Article
Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation
20 Jan 2023
Abstract excerpt
PURPOSE Immunopeptidome divergence between mismatched HLA-DP is a determinant of T-cell alloreactivity and clinical tolerability after fully HLA-A, -B, -C, -DRB1, -DQB1 matched unrelated donor hematopoietic cell transplantation (UD-HCT). Here, we tested this concept in HLA-A, -B, and -C disparities after single class I HLA-mismatched UD-HCT. PATIENTS AND METHODS We studied 2,391 single class I HLA-mismatched and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
